Krystal Biotech (KRYS) IPO Opens Modestly Higher
Get Alerts KRYS Hot Sheet
Join SI Premium – FREE
Today's IPO for Krystal Biotech (NASDAQ: KRYS) opened for trading at $10.50 after pricing 3,960,000 shares of common stock at a price to the public of $10.00 per share.
In addition, Krystal has granted the underwriters a 30-day option to purchase up to an additional 594,000 shares of common stock to cover over-allotments, if any.
Ladenburg Thalmann & Co. Inc., a subsidiary of Ladenburg Thalmann Financial Services Inc., is acting as sole book-running manager in connection with the offering.
Krystal Biotech, Inc. (NASDAQ: KRYS) is a gene therapy company dedicated to developing and commercializing novel treatments for patients suffering from dermatological diseases
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rubrik IPO: 5 key things to know
- Ibotta (IBTA) starts trading at $118, price IPO at $88
- Junee Ltd (JUNE) Prices 2M Share IPO at $4/sh
Create E-mail Alert Related Categories
IPOsRelated Entities
Ladenburg Thalmann Financial Services, IPOSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!